447 filings
Page 5 of 23
6-K
5fcp9kl h6mc
18 Feb 21
Current report (foreign)
10:19am
6-K
8nr11
11 Feb 21
Current report (foreign)
4:44pm
FWP
5y8 h2uz4inrqf96mcl8
8 Feb 21
Free writing prospectus
10:31am
424B3
f4t3n7a30ej8v241l9j8
8 Feb 21
Prospectus supplement
8:56am
6-K
w2d9 o0ht
8 Feb 21
Current report (foreign)
8:44am
6-K
k1h1 psbs
8 Feb 21
Current report (foreign)
6:11am
6-K
pxn6zja9pkomu8tfr3h
4 Feb 21
Current report (foreign)
3:23pm
6-K
9x7yvf37gnc5mnd3
2 Feb 21
Current report (foreign)
11:11am
6-K
u4l7td 7tt4p2epun0
8 Jan 21
Biofrontera announces preliminary revenue figures for the full year 2020
2:17pm
6-K
r1o4obinp6r
7 Jan 21
Current report (foreign)
3:22pm
6-K
j8t v102y9qfji7k5ar
6 Jan 21
Current report (foreign)
6:37am
S-8
aic 1dgkd4psr4w0
28 Dec 20
Registration of securities for employees
6:06am
6-K
97jj93ns5 bn7v3cn
22 Dec 20
Current report (foreign)
12:05pm
6-K
jpvlhyvntiwo0u2
7 Dec 20
Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz® in Scandinavia
10:01am
SC 13D/A
umet7
27 Nov 20
Biofrontera / DEUTSCHE BALATON AKTIENGESELLSCHAFT ownership change
4:04pm
6-K
4kqtpgr98zla fm33
27 Nov 20
Current report (foreign)
6:12am
6-K
ulwaj3syi1vrutxu bko
23 Nov 20
Managers’ transactions announcement according to article 19 MAR
3:57pm
6-K
wocen4 v40wa82
23 Nov 20
Managers’ transactions announcement according to article 19 MAR
3:56pm
6-K
avzm7sxn
23 Nov 20
Managers’ transactions announcement according to article 19 MAR
3:53pm
6-K
evwpf2o 1bv8pinxn
23 Nov 20
Current report (foreign)
7:17am